Cargando…

Pharmacological inhibition of acetylcholine-regulated potassium current (I(K,ACh)) prevents atrial arrhythmogenic changes in a rat model of repetitive obstructive respiratory events

BACKGROUND: In obstructive sleep apnea (OSA), intermittent hypoxemia and intrathoracic pressure fluctuations may increase atrial fibrillation (AF) susceptibility by cholinergic activation. OBJECTIVE: To investigate short-term atrial electrophysiological consequences of obstructive respiratory events...

Descripción completa

Detalles Bibliográficos
Autores principales: Linz, Benedikt, Thostrup, Anne Hauge, Saljic, Arnela, Rombouts, Karlijn, Hertel, Julie Norup, Hohl, Mathias, Milnes, James, Tfelt-Hansen, Jacob, Linz, Dominik, Jespersen, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859790/
https://www.ncbi.nlm.nih.gov/pubmed/35243441
http://dx.doi.org/10.1016/j.hroo.2021.11.013
_version_ 1784654534474203136
author Linz, Benedikt
Thostrup, Anne Hauge
Saljic, Arnela
Rombouts, Karlijn
Hertel, Julie Norup
Hohl, Mathias
Milnes, James
Tfelt-Hansen, Jacob
Linz, Dominik
Jespersen, Thomas
author_facet Linz, Benedikt
Thostrup, Anne Hauge
Saljic, Arnela
Rombouts, Karlijn
Hertel, Julie Norup
Hohl, Mathias
Milnes, James
Tfelt-Hansen, Jacob
Linz, Dominik
Jespersen, Thomas
author_sort Linz, Benedikt
collection PubMed
description BACKGROUND: In obstructive sleep apnea (OSA), intermittent hypoxemia and intrathoracic pressure fluctuations may increase atrial fibrillation (AF) susceptibility by cholinergic activation. OBJECTIVE: To investigate short-term atrial electrophysiological consequences of obstructive respiratory events, simulated by intermittent negative upper airway pressure (INAP), and the role of atrial acetylcholine-regulated potassium current (I(K,ACh)) activated by the M(2) receptor. METHODS: In sedated (2% isoflurane), spontaneously breathing rats, INAP was applied noninvasively by a negative pressure device for 1 minute, followed by a resting period of 4 minutes. INAP was applied repeatedly throughout 70 minutes, followed by a 2-hour recovery period. Atrial effective refractory period (AERP) and AF inducibility were determined throughout the protocol. To study INAP-induced I(K,ACh) activation, protein levels of protein kinase C (PKC(Ɛ)) were determined in membrane and cytosolic fractions of left atrial (LA) tissue by Western blotting. Moreover, an I(K,ACh) inhibitor (XAF-1407: 1 mg/kg) and a muscarinic receptor inhibitor (atropine: 1 μg/kg) were investigated. RESULTS: In vehicle-treated rats, repetitive INAP shortened AERP (37 ± 3 ms vs baseline 44 ± 3 ms; P = .001) and increased LA membrane PKC(Ɛ) content relative to cytosolic levels. Upon INAP recovery, ratio of PKC(Ɛ) membrane to cytosol content normalized and INAP-induced AERP shortening reversed. Both XAF-1407 and atropine increased baseline AERP (control vs XAF-1407: 61 ± 4 ms; P > .001 and control vs atropine: 58 ± 3 ms; P = .011) and abolished INAP-associated AERP shortening. CONCLUSION: Short-term simulated OSA is associated with a progressive, but transient, AERP shortening and a PKC(Ɛ) translocation to LA membrane. Pharmacological I(K,ACh) and muscarinic receptor inhibition prevented transient INAP-induced AERP shortening, suggesting an involvement of I(K,ACh) in the transient arrhythmogenic AF substrate in OSA.
format Online
Article
Text
id pubmed-8859790
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88597902022-03-02 Pharmacological inhibition of acetylcholine-regulated potassium current (I(K,ACh)) prevents atrial arrhythmogenic changes in a rat model of repetitive obstructive respiratory events Linz, Benedikt Thostrup, Anne Hauge Saljic, Arnela Rombouts, Karlijn Hertel, Julie Norup Hohl, Mathias Milnes, James Tfelt-Hansen, Jacob Linz, Dominik Jespersen, Thomas Heart Rhythm O2 Experimental BACKGROUND: In obstructive sleep apnea (OSA), intermittent hypoxemia and intrathoracic pressure fluctuations may increase atrial fibrillation (AF) susceptibility by cholinergic activation. OBJECTIVE: To investigate short-term atrial electrophysiological consequences of obstructive respiratory events, simulated by intermittent negative upper airway pressure (INAP), and the role of atrial acetylcholine-regulated potassium current (I(K,ACh)) activated by the M(2) receptor. METHODS: In sedated (2% isoflurane), spontaneously breathing rats, INAP was applied noninvasively by a negative pressure device for 1 minute, followed by a resting period of 4 minutes. INAP was applied repeatedly throughout 70 minutes, followed by a 2-hour recovery period. Atrial effective refractory period (AERP) and AF inducibility were determined throughout the protocol. To study INAP-induced I(K,ACh) activation, protein levels of protein kinase C (PKC(Ɛ)) were determined in membrane and cytosolic fractions of left atrial (LA) tissue by Western blotting. Moreover, an I(K,ACh) inhibitor (XAF-1407: 1 mg/kg) and a muscarinic receptor inhibitor (atropine: 1 μg/kg) were investigated. RESULTS: In vehicle-treated rats, repetitive INAP shortened AERP (37 ± 3 ms vs baseline 44 ± 3 ms; P = .001) and increased LA membrane PKC(Ɛ) content relative to cytosolic levels. Upon INAP recovery, ratio of PKC(Ɛ) membrane to cytosol content normalized and INAP-induced AERP shortening reversed. Both XAF-1407 and atropine increased baseline AERP (control vs XAF-1407: 61 ± 4 ms; P > .001 and control vs atropine: 58 ± 3 ms; P = .011) and abolished INAP-associated AERP shortening. CONCLUSION: Short-term simulated OSA is associated with a progressive, but transient, AERP shortening and a PKC(Ɛ) translocation to LA membrane. Pharmacological I(K,ACh) and muscarinic receptor inhibition prevented transient INAP-induced AERP shortening, suggesting an involvement of I(K,ACh) in the transient arrhythmogenic AF substrate in OSA. Elsevier 2021-11-19 /pmc/articles/PMC8859790/ /pubmed/35243441 http://dx.doi.org/10.1016/j.hroo.2021.11.013 Text en © 2021 Heart Rhythm Society. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Experimental
Linz, Benedikt
Thostrup, Anne Hauge
Saljic, Arnela
Rombouts, Karlijn
Hertel, Julie Norup
Hohl, Mathias
Milnes, James
Tfelt-Hansen, Jacob
Linz, Dominik
Jespersen, Thomas
Pharmacological inhibition of acetylcholine-regulated potassium current (I(K,ACh)) prevents atrial arrhythmogenic changes in a rat model of repetitive obstructive respiratory events
title Pharmacological inhibition of acetylcholine-regulated potassium current (I(K,ACh)) prevents atrial arrhythmogenic changes in a rat model of repetitive obstructive respiratory events
title_full Pharmacological inhibition of acetylcholine-regulated potassium current (I(K,ACh)) prevents atrial arrhythmogenic changes in a rat model of repetitive obstructive respiratory events
title_fullStr Pharmacological inhibition of acetylcholine-regulated potassium current (I(K,ACh)) prevents atrial arrhythmogenic changes in a rat model of repetitive obstructive respiratory events
title_full_unstemmed Pharmacological inhibition of acetylcholine-regulated potassium current (I(K,ACh)) prevents atrial arrhythmogenic changes in a rat model of repetitive obstructive respiratory events
title_short Pharmacological inhibition of acetylcholine-regulated potassium current (I(K,ACh)) prevents atrial arrhythmogenic changes in a rat model of repetitive obstructive respiratory events
title_sort pharmacological inhibition of acetylcholine-regulated potassium current (i(k,ach)) prevents atrial arrhythmogenic changes in a rat model of repetitive obstructive respiratory events
topic Experimental
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859790/
https://www.ncbi.nlm.nih.gov/pubmed/35243441
http://dx.doi.org/10.1016/j.hroo.2021.11.013
work_keys_str_mv AT linzbenedikt pharmacologicalinhibitionofacetylcholineregulatedpotassiumcurrentikachpreventsatrialarrhythmogenicchangesinaratmodelofrepetitiveobstructiverespiratoryevents
AT thostrupannehauge pharmacologicalinhibitionofacetylcholineregulatedpotassiumcurrentikachpreventsatrialarrhythmogenicchangesinaratmodelofrepetitiveobstructiverespiratoryevents
AT saljicarnela pharmacologicalinhibitionofacetylcholineregulatedpotassiumcurrentikachpreventsatrialarrhythmogenicchangesinaratmodelofrepetitiveobstructiverespiratoryevents
AT romboutskarlijn pharmacologicalinhibitionofacetylcholineregulatedpotassiumcurrentikachpreventsatrialarrhythmogenicchangesinaratmodelofrepetitiveobstructiverespiratoryevents
AT herteljulienorup pharmacologicalinhibitionofacetylcholineregulatedpotassiumcurrentikachpreventsatrialarrhythmogenicchangesinaratmodelofrepetitiveobstructiverespiratoryevents
AT hohlmathias pharmacologicalinhibitionofacetylcholineregulatedpotassiumcurrentikachpreventsatrialarrhythmogenicchangesinaratmodelofrepetitiveobstructiverespiratoryevents
AT milnesjames pharmacologicalinhibitionofacetylcholineregulatedpotassiumcurrentikachpreventsatrialarrhythmogenicchangesinaratmodelofrepetitiveobstructiverespiratoryevents
AT tfelthansenjacob pharmacologicalinhibitionofacetylcholineregulatedpotassiumcurrentikachpreventsatrialarrhythmogenicchangesinaratmodelofrepetitiveobstructiverespiratoryevents
AT linzdominik pharmacologicalinhibitionofacetylcholineregulatedpotassiumcurrentikachpreventsatrialarrhythmogenicchangesinaratmodelofrepetitiveobstructiverespiratoryevents
AT jespersenthomas pharmacologicalinhibitionofacetylcholineregulatedpotassiumcurrentikachpreventsatrialarrhythmogenicchangesinaratmodelofrepetitiveobstructiverespiratoryevents